Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Nolpaza 20 mg Gastro-Resistant Tablets.
Pharmaceutical Form |
---|
Gastro-resistant tablet. A light brownish yellow, oval, slightly biconvex tablet. |
Each gastro-resistant tablet contains 20 mg pantoprazole (as pantoprazole sodium sesquihydrate).
Excipient with known effect: sorbitol 18 mg/tablet.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Pantoprazole |
Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells. |
List of Excipients |
---|
Tablet core: Mannitol Film coating: Hypromellose |
Blister pack (OPA/Aluminium/PVC film and aluminium foil) in a carton box. Pack-sizes of 7, 14, 15, 28, 30, 56, 60, 84, 100, 100 × 1, 112 or 140 gastro-resistant tablets.
HDPE containers with a silica gel desiccant in a tamper evident PP screw-cap. Pack-size of 250 gastro-resistant tablets.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
PA1347/006/001
Date of first authorisation: 13th March 2009
Date of last renewal: 15th August 2016
Drug | Countries | |
---|---|---|
NOLPAZA | Austria, Estonia, Spain, Croatia, Ireland, Italy, Lithuania, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.